Cargando…

Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy

Cardiac amyloidosis can occasionally demonstrate an atypical pattern of infiltration, causing asymmetric septal thickening and a left ventricular outflow tract (LVOT) gradient with systolic anterior motion (SAM) of the mitral valve resembling obstructive hypertrophic cardiomyopathy. We present a cas...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanta, Lauren E., Ewer, Steven M., Gimelli, Giorgio, Reilly, Nicole M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825832/
https://www.ncbi.nlm.nih.gov/pubmed/36153647
http://dx.doi.org/10.1002/ccd.30411
_version_ 1784866708517814272
author Fanta, Lauren E.
Ewer, Steven M.
Gimelli, Giorgio
Reilly, Nicole M.
author_facet Fanta, Lauren E.
Ewer, Steven M.
Gimelli, Giorgio
Reilly, Nicole M.
author_sort Fanta, Lauren E.
collection PubMed
description Cardiac amyloidosis can occasionally demonstrate an atypical pattern of infiltration, causing asymmetric septal thickening and a left ventricular outflow tract (LVOT) gradient with systolic anterior motion (SAM) of the mitral valve resembling obstructive hypertrophic cardiomyopathy. We present a case of a 70‐year‐old man with cardiac light‐chain amyloidosis and LVOT obstruction successfully treated with alcohol septal ablation (ASA). Following the procedure, he reported significant improvement in his heart failure symptoms as well as improvement in LVOT gradient and SAM of the mitral valve. This case demonstrates that ASA is a technically feasible and effective procedure for relieving LVOT obstruction in cardiac amyloidosis and can be considered as a treatment option in patients whose symptoms are refractory to medical therapy.
format Online
Article
Text
id pubmed-9825832
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-98258322023-01-09 Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy Fanta, Lauren E. Ewer, Steven M. Gimelli, Giorgio Reilly, Nicole M. Catheter Cardiovasc Interv Valvular and Structural Heart Diseases Cardiac amyloidosis can occasionally demonstrate an atypical pattern of infiltration, causing asymmetric septal thickening and a left ventricular outflow tract (LVOT) gradient with systolic anterior motion (SAM) of the mitral valve resembling obstructive hypertrophic cardiomyopathy. We present a case of a 70‐year‐old man with cardiac light‐chain amyloidosis and LVOT obstruction successfully treated with alcohol septal ablation (ASA). Following the procedure, he reported significant improvement in his heart failure symptoms as well as improvement in LVOT gradient and SAM of the mitral valve. This case demonstrates that ASA is a technically feasible and effective procedure for relieving LVOT obstruction in cardiac amyloidosis and can be considered as a treatment option in patients whose symptoms are refractory to medical therapy. John Wiley and Sons Inc. 2022-09-24 2022-11-01 /pmc/articles/PMC9825832/ /pubmed/36153647 http://dx.doi.org/10.1002/ccd.30411 Text en © 2022 The Authors. Catheterization and Cardiovascular Interventions published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Valvular and Structural Heart Diseases
Fanta, Lauren E.
Ewer, Steven M.
Gimelli, Giorgio
Reilly, Nicole M.
Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
title Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
title_full Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
title_fullStr Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
title_full_unstemmed Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
title_short Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy
title_sort alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: new indication for an established therapy
topic Valvular and Structural Heart Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825832/
https://www.ncbi.nlm.nih.gov/pubmed/36153647
http://dx.doi.org/10.1002/ccd.30411
work_keys_str_mv AT fantalaurene alcoholseptalablationforleftventricularoutflowtractobstructionincardiacamyloidosisnewindicationforanestablishedtherapy
AT ewerstevenm alcoholseptalablationforleftventricularoutflowtractobstructionincardiacamyloidosisnewindicationforanestablishedtherapy
AT gimelligiorgio alcoholseptalablationforleftventricularoutflowtractobstructionincardiacamyloidosisnewindicationforanestablishedtherapy
AT reillynicolem alcoholseptalablationforleftventricularoutflowtractobstructionincardiacamyloidosisnewindicationforanestablishedtherapy